Serial #79438465
LIVE

Serial Number

79438465

Owner

C the Signs Limited

Attorney

Jordan Arnot Leahey

Filing Date

Sep 9, 2025

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79438465 Trademark

Serial Number: 79438465

Serial #79438465 is a trademark filed by C the Signs Limited on September 9, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

C the Signs Limited (5 trademarks)

1-7 Harley Street
London W1G9QD , GB

Entity Type: 99

Trademark Details

Filing Date

September 9, 2025

Registration Date

Not Registered

Published for Opposition

June 23, 2026

Goods & Services

Educational and training services relating to healthcare, namely, conducting training, workshops, classes in the field of healthcare; education services, namely, conducting training, workshops, classes in the field of healthcare; providing of training in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients, rendered through correspondence courses; teaching in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; arranging and conducting of conferences, seminars and training workshops in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; providing education in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients rendered through correspondence courses; educational services, namely, conducting classes, workshops, seminars in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; vocational guidance; organisation of exhibitions for educational purposes; providing on-line non-downloadable electronic publications in the nature of books, magazines, brochures, leaflets in the field of cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

Data processing services in the field of healthcare; data management, namely, database management, computer data entry services; data processing services; database management; computer data entry services and data processing services; compilation of data for business purposes; automated data processing services; electronic data collection services for business purposes in the fields of medicine and healthcare; systematization of data in computer databases; collating of data in computer databases, namely, compilation and systemization of information into computer databases; market research data analysis; online data processing services; preparation of healthcare statistical data, namely, providing statistical healthcare information for business or commercial purposes; dissemination of data relating to healthcare, namely, providing business information in the field of healthcare, database processing services; data and database improvement, namely, updating and maintenance of data in computer databases; data and database enhancement, namely, updating and maintenance of data in computer databases; combining data from multiple sources into databases, namely, systemization of data in computer databases; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

Recorded and downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; computer software platforms, recorded or downloadable for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; recorded and downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; digital media, namely, downloadable audio and audiovisual recordings featuring information and advice relating to cancer risk, cancer diagnosis, cancer treatment and the clinical needs of patients; multi-platform digital tools, namely, recorded and downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; all of the aforesaid goods for use in relation to and relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

Healthcare; medical services; hospital services and medical clinics; medical assistance; nursing services; health screening services in the field of cancer; medical information; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients; advisory and consultancy services relating to all of the aforesaid and none of the aforesaid relating to the testing and screening of neurological conditions

Information technology services for the pharmaceutical and healthcare industries, namely, providing information technology consulting services relating to computer network design, computer software design, and relating to installation, maintenance and repair of computer software, and providing temporary use of online non- downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable artificial intelligence software for healthcare for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non- downloadable software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non- downloadable software applications for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable computer software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable smartphone software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing temporary use of online non-downloadable mobile application software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; software as a service (SaaS) services featuring software for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; platform as a service (PaaS) services featuring computer software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software platforms for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; providing online, non-downloadable software, software as a service (SaaS) services featuring software, platform as a service (PaaS) services featuring computer software platforms and online, non-downloadable software platforms all for assessing cancer risk, diagnosing cancer, treating cancer and assessing the clinical needs of cancer patients; information, advisory and consultancy services relating to all of the aforesaid; all of the aforesaid services relating only to assessing cancer risk, cancer diagnosis, cancer treatment and assessing the clinical needs of cancer patients and none of the aforesaid relating to the testing and screening of neurological conditions

Filing History

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 3, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 3, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
May 22, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 19, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 19, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2026 TROA
REFUSAL PROCESSED BY IB
Mar 5, 2026 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 19, 2026 RFCS
REFUSAL PROCESSED BY MPU
Feb 19, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 24, 2026 RFCR
NON-FINAL ACTION WRITTEN
Jan 23, 2026 CNRT
ASSIGNED TO EXAMINER
Jan 22, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 15, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 15, 2025 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 15, 2025 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 4, 2025 REPR